Monetary Management Group Inc. Cuts Stake in Humana Inc. (NYSE:HUM)

Monetary Management Group Inc. lessened its stake in shares of Humana Inc. (NYSE:HUM) by 31.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,137 shares of the insurance provider’s stock after selling 1,000 shares during the period. Monetary Management Group Inc.’s holdings in Humana were worth $542,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in HUM. Vanguard Group Inc. increased its stake in shares of Humana by 15.8% during the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares during the last quarter. Pzena Investment Management LLC grew its holdings in Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock valued at $915,736,000 after purchasing an additional 1,103,132 shares during the period. Geode Capital Management LLC increased its position in Humana by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider’s stock worth $729,658,000 after buying an additional 63,562 shares during the last quarter. Invesco Ltd. increased its position in Humana by 29.8% in the fourth quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider’s stock worth $608,348,000 after buying an additional 550,692 shares during the last quarter. Finally, Norges Bank purchased a new position in shares of Humana during the 4th quarter valued at $416,202,000. Institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

HUM has been the subject of several recent research reports. Guggenheim assumed coverage on Humana in a report on Wednesday. They issued a “buy” rating and a $326.00 price objective for the company. Barclays lifted their target price on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Piper Sandler upped their price target on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. Morgan Stanley reduced their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 12th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. Seventeen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $284.25.

Humana Price Performance

HUM stock opened at $290.83 on Friday. The firm has a 50 day simple moving average of $265.56 and a two-hundred day simple moving average of $270.77. The stock has a market cap of $35.10 billion, a PE ratio of 29.23, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.22%. Humana’s dividend payout ratio is 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.